At Manapharma, we take pride in driving innovation and creating value for our partners across both the
pharmaceutical and personal care industries. Through strategic collaborations, advanced technologies,
and technical expertise, we have introduced breakthrough solutions that empower local manufacturers,
strengthen international partnerships, and elevate Egypt’s healthcare and personal care ecosystems.
In partnership with UNIDO, Manapharma successfully implemented a major technology transfer program, transitioning MDI inhalation manufacturing in Egypt from CFC to HFA propellant improving environmental sustainability and product efficacy.
Leveraging our strong portfolio in inhalation products, we facilitated multiple registrations for generic Dry Powder Inhalers (DPI) with our customers expanding patient access to essential treatments.
By securing raw materials approvals with local multinational companies, Manapharma enabled our API partners to supply these companies globally.
Manapharma introduced advanced blister foil technology solutions to the Egyptian market to overcome Alu Alu packaging challenges and enhancing product shelf life.
Manapharma has played a key role in elevating Egypt’s personal care sector by introducing advanced beauty technologies, strengthening local formulation capabilities, and supporting brands in developing high-performance products. Through our partnerships with global innovators, we have enabled manufacturers to adopt trends such as bond repair, microbiome-friendly protection, long-lasting conditioning, and next-generation functional ingredients.
